,Keyword_1,frequency,Keyword_2,degreee
0,tissue engineering,11,tissue engineering,33
1,artificial immune system,11,artificial immune system,29
2,immune response,8,immune response,26
3,immune system,8,immune system,23
4,inflammation,7,immunotherapy,22
5,immunotherapy,6,inflammation,21
6,nanoparticles,5,macrophage,16
7,fault diagnosis,5,cancer,13
8,cancer,3,nanoparticles,12
9,mesenchymal stem cells,3,cd47,12
10,transplantation,3,fault diagnosis,12
11,macrophage,3,transplantation,10
12,optimization,3,allogeneic,9
13,artificial immune systems,3,stem cells,8
14,cell proliferation,2,hydrogel,8
15,osteogenic,2,regenerative medicine,8
16,biocompatibility,2,optimization,8
17,clonal selection algorithm,2,antibodies,8
18,vaccination,2,scaffold,8
19,stem cells,2,osteogenic,7
20,3d printing,2,3d printing,7
21,hydrogel,2,hiv,7
22,hiv,2,gene,7
23,gene,2,graft-versus-host disease,7
24,graft-versus-host disease,2,immunology,7
25,graft,2,macrophages,7
26,allogeneic,2,immunosuppression,7
27,regenerative medicine,2,xenotransplantation,7
28,immunology,2,cell proliferation,6
29,macrophages,2,biocompatibility,6
30,vascularization,2,st6gal,6
31,cancer immunotherapy,2,st3gal,6
32,immune checkpoint,2,sialyllactose,6
33,cd47,2,poikilotherm,6
34,immune,2,ella,6
35,innate immunity,2,hilic-hplc,6
36,dendritic cells,2,cho,6
37,identification,2,mesenchymal stem cells,6
38,particulate,2,graft,6
39,immunosuppression,2,cancer immunotherapy,6
40,antibodies,2,b cell,6
41,biomaterials,2,human,6
42,xenotransplantation,2,humanized mouse,6
43,scaffold,2,miniature swine,6
44,artificial immune,2,mixed,6
45,antigen,2,immune,6
46,electrospinning,1,innate immunity,6
47,xeno-free scaffold,1,identification,6
48,human umbilical cord,1,particulate,6
49,collagen,1,artificial immune systems,6
50,cytotoxicity,1,antibody,6
51,cell adhesion,1,sirpa,6
52,alumina,1,phagocytosis,6
53,cell responses,1,antigen,6
54,protein adsorption,1,vaccination,5
55,probiotic yeasts,1,hcv,5
56,olive oil yeasts,1,cd81,5
57,virgin olive oil,1,retrovirus,5
58,bacterial infection in mussels,1,e2,5
59,copper oxide nanoparticles,1,e1,5
60,hemocytes,1,transport,5
61,complete receptor editing,1,hcmv,5
62,quantum,1,tcr,5
63,computer-aided antibody engineering,1,cd8 t cell,5
64,affinity improvement,1,ifn-gamma,5
65,ibalizumab,1,hsct,5
66,hybrid hydrogels,1,nanomaterials,5
67,microporous network,1,stealth,5
68,reverse thermal gel,1,biomimetic,5
69,neural tube defects,1,bio-corona,5
70,myelomeningocele,1,targeting,5
71,prenatal,1,fasl,5
72,tumor necrosis factor receptor,1,immune tolerance,5
73,anti-tnf effect,1,plg,5
74,prokaryotic expression,1,polymer scaffold,5
75,chondrocytes,1,islet,5
76,hypertrophy,1,vascularization,5
77,arthritis,1,immune checkpoint,5
78,wnt/beta-catenin,1,biomaterials,5
79,angiogenesis,1,clonal selection algorithm,4
80,microfluidics,1,chondrocytes,4
81,blood brain barrier,1,hypertrophy,4
82,permeability,1,arthritis,4
83,chitosan,1,wnt/beta-catenin,4
84,articular cartilage,1,chitosan,4
85,decellularized spleen matrix,1,articular cartilage,4
86,bioartificial liver,1,sesbania aegyptica,4
87,hemocompatibility,1,silver nanoparticles,4
88,sesbania aegyptica,1,peg,4
89,silver nanoparticles,1,arginase,4
90,peg,1,mdsc,4
91,gold nanomaterial,1,arginine,4
92,iodine-124,1,metabolic checkpoint,4
93,radioactive imaging tracers,1,aminoacid,4
94,positron,1,tat,4
95,st6gal,1,methamphetamine,4
96,st3gal,1,tata-box,4
97,sialyllactose,1,tata-box binding peptide,4
98,poikilotherm,1,glioma,4
99,ella,1,tumorsphere,4
100,hilic-hplc,1,microscale niche,4
101,cho,1,time series assessment,4
102,"alpha-2,6-sialyltransferase",1,hypoxic,4
103,linked lectin assay,1,t,4
104,iron oxide,1,hepatitis c virus,4
105,dendron,1,ns3,4
106,oligoethyleneglycol,1,helicase,4
107,polyethylene-glycol peg,1,immunodiagnostic,4
108,in-vitro toxicity,1,seroconversion,4
109,hcv,1,immunomodulation,4
110,cd81,1,immunogenicity,4
111,retrovirus,1,chondrogenic,4
112,e2,1,immune subsets,4
113,e1,1,allografts,4
114,transport,1,outcomes,4
115,3d encapsulation,1,relapse,4
116,advanced technologies,1,dendritic cells,4
117,adoptive t-cell therapy,1,organoids,4
118,tumour microenvironment,1,spatio-temporal,4
119,arginase,1,adhesive,4
120,mdsc,1,lymph node,4
121,arginine,1,editorial,4
122,metabolic checkpoint,1,personal viewpoint,4
123,aminoacid,1,immunobiology,4
124,immobilized,1,adjuvant,4
125,antibacterial activity,1,exosomes,4
126,imipenem,1,nef,4
127,gold nanoparticles,1,hpv-e6,4
128,tat,1,cd8(+) t immune response,4
129,methamphetamine,1,fab fragments,4
130,tata-box,1,monobodies,4
131,tata-box binding peptide,1,nanobodies,4
132,hcmv,1,protein engineering,4
133,tcr,1,implant,4
134,cd8 t cell,1,stem cell,4
135,ifn-gamma,1,engineered heart tissue,4
136,hsct,1,rat,4
137,bioactive nanoparticles,1,rejection,4
138,peptide,1,glioblastoma,4
139,nanodrug,1,vaccines,4
140,anti-inflammatory,1,monoclonal,4
141,recombination-activating gene 2,1,artificial immune,4
142,vdj recombination,1,mhc class i,4
143,severe combined,1,learning,4
144,bispecific,1,hierarchy,4
145,lymph nodes,1,clonal,4
146,cure,1,finite element,4
147,glioma,1,mesh-distortion,4
148,tumorsphere,1,isoparametric,4
149,microscale niche,1,shape functions,4
150,time series assessment,1,element,4
151,hypoxic,1,tolerance,4
152,imatinib,1,tissue,4
153,discontinuation,1,pig,4
154,naive t cells,1,primate,4
155,t-lymphocyte subsets,1,humoral rejection,4
156,nanomaterials,1,genetic,4
157,stealth,1,electrospinning,3
158,biomimetic,1,xeno-free scaffold,3
159,bio-corona,1,human umbilical cord,3
160,targeting,1,collagen,3
161,m cell,1,cytotoxicity,3
162,engineered materials,1,cell adhesion,3
163,mucosal vaccination,1,alumina,3
164,mucosa-associated,1,cell responses,3
165,fasl,1,protein adsorption,3
166,immune tolerance,1,hybrid hydrogels,3
167,plg,1,microporous network,3
168,polymer scaffold,1,reverse thermal gel,3
169,islet,1,neural tube defects,3
170,t,1,myelomeningocele,3
171,brain tissue,1,prenatal,3
172,brain damage,1,angiogenesis,3
173,human bone marrow derived mesenchymal stromal cells,1,microfluidics,3
174,chondrogenesis,1,blood brain barrier,3
175,lipopolysaccharide (lps),1,permeability,3
176,structure elucidation,1,gold nanomaterial,3
177,nmr,1,iodine-124,3
178,mass spectrometry,1,radioactive imaging tracers,3
179,poria cocos,1,positron,3
180,immunomodulatory protein,1,iron oxide,3
181,pichia pastoris,1,dendron,3
182,purification,1,oligoethyleneglycol,3
183,vessel development,1,adoptive t-cell therapy,3
184,macrophage phenotypes,1,tumour microenvironment,3
185,photobiomodulation,1,immobilized,3
186,low level light therapy,1,antibacterial activity,3
187,hepatitis c virus,1,imipenem,3
188,ns3,1,gold nanoparticles,3
189,helicase,1,bioactive nanoparticles,3
190,immunodiagnostic,1,peptide,3
191,seroconversion,1,nanodrug,3
192,crispr-cas systems,1,anti-inflammatory,3
193,adaptive immunity,1,bispecific,3
194,self versus non-self,1,lymph nodes,3
195,3d human placenta-on-a-chip,1,cure,3
196,nanoparticle exposure,1,imatinib,3
197,organ-on-a -chip,1,discontinuation,3
198,porous tracheal scaffold,1,naive t cells,3
199,pcl,1,t-lymphocyte subsets,3
200,surface modifications,1,m cell,3
201,lymphangiogenesis,1,engineered materials,3
202,disease modeling,1,mucosal vaccination,3
203,wound healing,1,mucosa-associated,3
204,oncolytic viruses,1,brain tissue,3
205,immune therapy,1,brain damage,3
206,transgenes,1,lipopolysaccharide (lps),3
207,cell therapy,1,structure elucidation,3
208,drug delivery,1,nmr,3
209,b cell,1,mass spectrometry,3
210,human,1,poria cocos,3
211,humanized mouse,1,immunomodulatory protein,3
212,miniature swine,1,pichia pastoris,3
213,mixed,1,purification,3
214,intelligent manufacturing system,1,vessel development,3
215,immune monitoring model,1,macrophage phenotypes,3
216,immunomodulation,1,porous tracheal scaffold,3
217,immunogenicity,1,pcl,3
218,chondrogenic,1,surface modifications,3
219,nanogold,1,lymphangiogenesis,3
220,rheumatoid arthritis,1,disease modeling,3
221,transcription factor,1,wound healing,3
222,immune subsets,1,cell therapy,3
223,allografts,1,drug delivery,3
224,outcomes,1,nanogold,3
225,relapse,1,rheumatoid arthritis,3
226,engineered nanoparticles,1,transcription factor,3
227,immunosafety,1,engineered nanoparticles,3
228,in-vivo,1,immunosafety,3
229,engineered,1,in-vivo,3
230,hybridization,1,engineered,3
231,tissue-engineered vascular graft,1,hybridization,3
232,congenital cardiac,1,bacteria,3
233,bacteria,1,biomimetic engineering,3
234,biomimetic engineering,1,polymeric scaffolds,3
235,engineered heart muscle,1,tissue engineered scaffolds,3
236,pluripotent stemcells,1,inflammatory responses,3
237,polymeric scaffolds,1,protein,3
238,organoids,1,cytokines,3
239,spatio-temporal,1,immuno-engineering,3
240,adhesive,1,autoimmune disease,3
241,lymph node,1,genome,3
242,editorial,1,engineering,3
243,personal viewpoint,1,editing,3
244,immunobiology,1,immune modulation,3
245,tissue engineered scaffolds,1,cell,3
246,inflammatory responses,1,aero-engine,3
247,protein,1,artificial immune theory,3
248,cytokines,1,oil analysis,3
249,t cellular immunotherapies,1,micropatterning,3
250,hepatocellular carcinoma,1,epithelial,3
251,adjuvant,1,t lymphocyte,3
252,exosomes,1,immune synapse,3
253,nef,1,specific immunotherapy,3
254,hpv-e6,1,guided missile,3
255,cd8(+) t immune response,1,myasthenia gravis,3
256,fab fragments,1,dendritic,3
257,monobodies,1,baculovirus,3
258,nanobodies,1,adipose-derived stem cells,3
259,protein engineering,1,clonal selection,3
260,t cell,1,fuzzy k-nn,3
261,t cell receptor (tcr),1,artificial immunity,3
262,chimeric antigen receptor (car),1,independent components analysis,3
263,immuno-engineering,1,ais-ica,3
264,autoimmune disease,1,fault,3
265,genome,1,genetic engineering,3
266,engineering,1,scid,3
267,editing,1,acquired immunity,3
268,immunocytokines,1,adoptive t cell therapy,3
269,bispecific antibodies,1,t cell receptor,3
270,immunotherapy of cancer,1,graft versus leukaemia,3
271,artificial immune algorithm,1,heart valve,3
272,selective ensemble,1,extracellular matrix,3
273,immune modulation,1,parallel,3
274,cell,1,motor fault diagnosis,3
275,implant,1,wavelet energy,3
276,stem cell,1,rbf,3
277,engineered heart tissue,1,composite scaffold,3
278,rat,1,peg-collagen,3
279,rejection,1,cell migration,3
280,heart valve tissue engineering,1,freeway,3
281,decellularization,1,ramp metering,3
282,cellular reseeding,1,artificial immune controller,3
283,immune cells,1,traffic flow model,3
284,glioblastoma,1,immune engineering,3
285,vaccines,1,natural,3
286,monoclonal,1,reconstructive surgery,3
287,fault detection,1,cartilage,3
288,distributed artificial intelligent,1,polyelectrolyte,3
289,spinal cord injury,1,self,3
290,immunoengineering,1,non-self,3
291,mechanical and electrical equipment,1,strings,3
292,self-healing,1,probiotic yeasts,2
293,immune principle,1,olive oil yeasts,2
294,awareness,1,virgin olive oil,2
295,autonomic computing,1,bacterial infection in mussels,2
296,multi-objectice,1,copper oxide nanoparticles,2
297,aero-engine,1,hemocytes,2
298,artificial immune theory,1,complete receptor editing,2
299,oil analysis,1,quantum,2
300,antibody,1,computer-aided antibody engineering,2
301,sirpa,1,affinity improvement,2
302,phagocytosis,1,ibalizumab,2
303,rockbolts,1,tumor necrosis factor receptor,2
304,nondestructive detection,1,anti-tnf effect,2
305,immune danger theory,1,prokaryotic expression,2
306,nonnegative matrix factorization,1,decellularized spleen matrix,2
307,relative warmth index,1,bioartificial liver,2
308,transitional spaces,1,hemocompatibility,2
309,non-steady state thermal,1,polyethylene-glycol peg,2
310,micropatterning,1,in-vitro toxicity,2
311,epithelial,1,3d encapsulation,2
312,t lymphocyte,1,advanced technologies,2
313,immune synapse,1,recombination-activating gene 2,2
314,particle swarm optimization,1,vdj recombination,2
315,specific immunotherapy,1,severe combined,2
316,guided missile,1,photobiomodulation,2
317,myasthenia gravis,1,low level light therapy,2
318,dendritic,1,crispr-cas systems,2
319,baculovirus,1,adaptive immunity,2
320,adipose-derived stem cells,1,self versus non-self,2
321,clonal selection,1,3d human placenta-on-a-chip,2
322,fuzzy k-nn,1,nanoparticle exposure,2
323,immune genetic algorithm (iga),1,organ-on-a -chip,2
324,bp neural network model,1,oncolytic viruses,2
325,dynamic,1,immune therapy,2
326,artificial immunity,1,transgenes,2
327,independent components analysis,1,intelligent manufacturing system,2
328,ais-ica,1,immune monitoring model,2
329,fault,1,tissue-engineered vascular graft,2
330,genetic engineering,1,congenital cardiac,2
331,scid,1,engineered heart muscle,2
332,acquired immunity,1,pluripotent stemcells,2
333,adoptive t cell therapy,1,t cellular immunotherapies,2
334,t cell receptor,1,hepatocellular carcinoma,2
335,graft versus leukaemia,1,t cell,2
336,mhc class i,1,t cell receptor (tcr),2
337,learning,1,chimeric antigen receptor (car),2
338,hierarchy,1,immunocytokines,2
339,clonal,1,bispecific antibodies,2
340,ship parts,1,immunotherapy of cancer,2
341,remaining rectangle matching,1,artificial immune algorithm,2
342,particle swarm algorithm,1,selective ensemble,2
343,constrained optimization,1,heart valve tissue engineering,2
344,metaheuristics,1,decellularization,2
345,heart valve,1,cellular reseeding,2
346,extracellular matrix,1,immune cells,2
347,cartilage tissue engineering,1,fault detection,2
348,foreign body response,1,distributed artificial intelligent,2
349,finite element,1,spinal cord injury,2
350,mesh-distortion,1,immunoengineering,2
351,isoparametric,1,mechanical and electrical equipment,2
352,shape functions,1,self-healing,2
353,element,1,immune principle,2
354,machine learning,1,awareness,2
355,frequency-variable air,1,autonomic computing,2
356,parallel,1,multi-objectice,2
357,motor fault diagnosis,1,rockbolts,2
358,wavelet energy,1,nondestructive detection,2
359,rbf,1,immune danger theory,2
360,parametric modelling,1,nonnegative matrix factorization,2
361,flexible plate,1,relative warmth index,2
362,immune clustering,1,transitional spaces,2
363,electric load,1,non-steady state thermal,2
364,division,1,particle swarm optimization,2
365,packing optimization,1,immune genetic algorithm (iga),2
366,niche skill,1,bp neural network model,2
367,immune genetic algorithm,1,dynamic,2
368,flt3 ligand,1,ship parts,2
369,expansion,1,remaining rectangle matching,2
370,natural immune systems,1,particle swarm algorithm,2
371,composite scaffold,1,constrained optimization,2
372,peg-collagen,1,metaheuristics,2
373,cell migration,1,cartilage tissue engineering,2
374,cortex,1,foreign body response,2
375,adhesion,1,machine learning,2
376,dynamic characteristic clustering,1,frequency-variable air,2
377,fuzzy artificial immune network,1,parametric modelling,2
378,dynamic clustering,1,flexible plate,2
379,artificial immune network,1,immune clustering,2
380,kernel-based possibility,1,electric load,2
381,tolerance,1,division,2
382,tissue,1,packing optimization,2
383,electromagnetic radiation,1,niche skill,2
384,radiation intensity,1,immune genetic algorithm,2
385,immune feedback control,1,flt3 ligand,2
386,main steam temperature system,1,expansion,2
387,autonomous guided vehicle,1,natural immune systems,2
388,multi-agent control,1,cortex,2
389,freeway,1,adhesion,2
390,ramp metering,1,dynamic clustering,2
391,artificial immune controller,1,artificial immune network,2
392,traffic flow model,1,kernel-based possibility,2
393,immune engineering,1,electromagnetic radiation,2
394,natural,1,radiation intensity,2
395,reconstructive surgery,1,immune feedback control,2
396,cartilage,1,main steam temperature system,2
397,polyelectrolyte,1,autonomous guided vehicle,2
398,pig,1,multi-agent control,2
399,primate,1,statistical mechanics,2
400,humoral rejection,1,original antigenic sin,2
401,genetic,1,"alpha-2,6-sialyltransferase",1
402,statistical mechanics,1,linked lectin assay,1
403,original antigenic sin,1,human bone marrow derived mesenchymal stromal cells,1
404,self,1,chondrogenesis,1
405,non-self,1,dynamic characteristic clustering,1
406,strings,1,fuzzy artificial immune network,1
407,bioengineered tissue,1,bioengineered tissue,1
408,graft rejection,1,graft rejection,1
409,antigen-presenting cells,1,antigen-presenting cells,1
